VAERS Reports UJ670AA

VAERS 2328854

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ670AA

gering

Staat: NY
Alter: 0,3
Geschlecht: F
Eingang: 23.06.2022
Impfdatum: 14.06.2022
Beginn: 14.06.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acidosis Blood culture negative Blood gases abnormal Blood methaemoglobin Cyanosis Echocardiogram normal Full blood count normal Laboratory test Laboratory test abnormal Musculoskeletal disorder Pallor Resuscitation Urine analysis normal Viral test negative

Symptomtext

Episode of limpness, pallor, and perioral cyanosis, lasting about 6 minutes. Treated at home with mouth to mouth resuscitation. Taken to ED, where a second episode, lasting about 3 minutes, occurred. Hospitalized x 2 days, with no further episodes or other symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acidosis
Hospital-Tage: 2,0
Labordaten: 6/14/2022: Mild acidosis on initial Chem 7, VBG. All other tests, including CBC, viral studies, blood culture, Echocardiogram, urine studies, methemoglobin evaluation, etc. were negative.
Aktuelle Erkrankungen: None at the time of infection. Covid -19, 2 weeks prior to infection
Vorgeschichte: Chronic nasal congestion., macroglossia
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2322974

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ670AA

gering

Staat: IL
Alter: -
Geschlecht: U
Eingang: 17.06.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product preparation error

Symptomtext

Medical assistant reports patient was given liquid component of PENTACEL but not powder with no adverse event; Initial information received on 07-Jun-2022 regarding an unsolicited valid non-serious case received from a other health professional via call center. This case involves a patient of unknown gender and age, medical assistant reports patient was given liquid component of pentacel but not powder with no adverse event while receiving vaccine Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)]. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On an unknown date, the patient received a dose of suspect diphtheria/tetanus/5 hybrid ac pertussis/ipv(vero)/hib(prp/t) vaccine (dose, strength, formulation, frequency: unknown) lot UJ670AA, U7256AB expiry date: 13-May-2023 via unknown route in unknown administration site as Immunization. On an unknown date the patient developed a non-serious event medical assistant reports patient was given liquid component of pentacel but not powder with no adverse event (product preparation error) (unknown latency) following the administration of diphtheria/tetanus/5 hybrid ac pertussis/ipv(vero)/hib(prp/t) vaccine. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (product preparation error). At time of reporting, the outcome was Unknown for the event product preparation error. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -